TrialClinical genitourinary cancer2018

Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial.

Yu-Ning Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.